文献速递疼痛医学神经外科与老年麻醉

抑制内质网氧化还原酶1调节小鼠神经元兴奋性与痛觉敏感性

Inhibition of Endoplasmic Reticulum Oxidoreductin 1 Modulates Neuronal Excitability and Nociceptive Sensitivity in Mice.
PubMed 文献 · Anesthesiology · 2025-03-19

该研究在小鼠急性和术后疼痛模型中验证抑制内质网氧化还原酶1(ERO1)能否降低伤害感受器超兴奋性。外周给予ERO1抑制剂可急性逆转伤害感受行为,体外抑制ERO1降低DRG神经元兴奋性和线粒体功能,人DRG也表达ERO1α且抑制后降低兴奋性,提示靶向ERO1或可用于非阿片类急性镇痛。

要点

  • ERO1α在小鼠及人DRG多种感觉神经元亚型中表达。
  • 外周抑制ERO1可急性逆转小鼠急性炎性和术后疼痛行为。
  • ERO1抑制降低DRG神经元兴奋性与线粒体功能,或由ERMCS钙转移减少介导。

核心结论

  • 抑制ERO1可降低小鼠线粒体功能、感觉神经元兴奋性和急性疼痛样行为。
  • ERO1抑制降低体外死后人感觉神经元兴奋性,靶向ERO1可能是非阿片类急性镇痛策略。

研究设计与样本

  • 使用C57BL/6小鼠进行组织学、行为学和细胞培养实验。
  • 行为学包括热甩尾、福尔马林足底注射急性炎性痛模型和足底切口术后痛模型。
  • 使用死后人背根神经节(DRG)进行免疫组化和体外钙成像。

主要发现

  • ERO1α在小鼠DRG多种感觉神经元亚型中表达。
  • 外周给予ERO1抑制剂急性逆转小鼠急性炎性和术后疼痛模型中的伤害感受。
  • 培养DRG中抑制ERO1减弱伤害感受器兴奋性和线粒体功能。
  • 免疫组化和已发表单细胞RNA测序数据显示人DRG表达ERO1α。
  • 抑制ERO1调节培养的死后人DRG感觉神经元兴奋性。

临床怎么用

  • 提示外周靶向ERO1可能成为非阿片类急性疼痛治疗方向,尚需临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the peripheral nervous system, nociceptors become hyperexcitable in both acute and chronic pain conditions. This phenotype can be mediated by dysregulated calcium, which occurs if the endoplasmic reticulum and mitochondria fail to buffer it appropriately. The redox enzyme endoplasmic reticulum oxidoreductin 1 (ERO1) regulates calcium transfer at endoplasmic reticulum-mitochondria contact sites (ERMCSs). This study hypothesized that inhibiting ERO1 and thereby dampening ERMCS calcium transfer might lower nociceptor hyperexcitability in sensory neurons and pain-like behaviors in mice. METHODS: C57BL/6 mice were used for histology, behavior, and cell culture experiments. Behavior included thermal tail flick, the formalin hind paw injection model of acute inflammatory pain, and hind paw incision postsurgical pain. Postmortem human dorsal root ganglia (DRGs) were used for immunohistochemistry and in vitro calcium imaging. RESULTS: This study demonstrates that the α isoform of ERO1 is expressed in mouse DRGs across multiple subtypes of mouse sensory neurons. This led us to peripherally administer an ERO1 inhibitor in mice, which acutely reversed nociception in acute inflammatory and postsurgical pain models. The hypothesis was that this may be due to reduced excitability of DRG neurons and tested ERO1 inhibition in vitro. In cultured DRGs, ERO1 inhibition dampened nociceptor excitability and mitochondrial function, suggesting that reduced calcium transfer through ERMCS could be responsible for the behavior observed in vivo . ERO1α expression was also found in human DRGs using immunohistochemistry and previously published single-cell RNA-sequencing data. Finally, the study showed that ERO1 inhibition modulates human sensory neuronal excitability in cultured post-mortem DRGs. CONCLUSIONS: This study found that ERO1 inhibition dampens mitochondrial function, sensory neuron excitability, and acute pain-like behavior in mice. Additionally, ERO1 inhibition decreases sensory neuron excitability in post-mortem human sensory neurons in vitro. The results indicate that targeting ERO1 may be a viable strategy for non-narcotic acute pain relief.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Maguire AD, Lamothe SM, Yousuf MS, et al. Inhibition of Endoplasmic Reticulum Oxidoreductin 1 Modulates Neuronal Excitability and Nociceptive Sensitivity in Mice. Anesthesiology. 2025. PMID: 40106735. doi:10.1097/ALN.0000000000005453

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。